KJT Welcomes Ellen Gordon, PhD

KJT Welcomes Ellen Gordon, PhD

KJT is thrilled to announce the newest addition to our Client Strategy team, Ellen Gordon, who will be joining us as a Senior Vice President of Client Strategy & Growth.

Ellen is an accomplished senior business development professional with extensive expertise in building and monetizing strategic relationships in the biopharmaceutical industry while delivering superior customer experiences. With a proven track record in identifying new business opportunities and capitalizing on them, Ellen brings a unique blend of subject matter expertise and business acumen to her role.

In her new position at KJT, Ellen will play a pivotal role in managing existing accounts while also spearheading new business development initiatives. Her strategic approach to client engagement and her ability to deliver value-added solutions align perfectly with KJT’s commitment to excellence and innovation.

Most recently, Ellen has been focused on delivering digital health and AI/ML solutions to pharmaceutical and biotech companies. Prior to joining KJT, Ellen was VP, Head of Business Development at Almaden Genomics, a platform company designed to streamline genomic workflows.  She also served as Vice President of Global Accounts at BrightInsight, a platform for biopharma and medtech regulated digital health solutions, Digital Ventures Lead for Memorial Sloan Kettering Cancer Center, and Executive Director of Business Development for GNS Healthcare.

Ellen holds a PhD in Political Science from the University of Michigan, an MA from Georgetown University, and a BA from Brandeis University.

“We are delighted to welcome Ellen to KJT. Ellen’s deep expertise and proven track record in sales will be invaluable as we continue to innovate and expand our reach in the healthcare sector. This addition underscores our commitment to attracting top talent and enhancing our capabilities to better serve our customers and improve patient outcomes. We look forward to the dynamic contributions Ellen will bring to our team,” said Michaela Gascon, President and CEO of KJT.

Blogs & News

Read More
Read More

Reflections on PMRC 2025: The AI Train Left the Station… “Next Stop”

I have attended more than half of the PMRC conferences held over the past 16 years. Being a veteran…

Read More
Read More

10 Best Practices in Conducting Ethnography in Rare Disease Population

Rare disease patients face unique challenges that are often overlooked or misunderstood by those…

Read More
Read More

KJT Welcomes Katherine Ephlin as Research, Executive Vice President

KJT, a leader in strategic research insights, real-world evidence and medical communications for…

Read More
Read More

How AI Will Impact the Value of Qualitative Insights

The healthcare industry is experiencing a seismic shift in how market research is conducted and…

Read More
Read More

Navigating Complex Patient Experiences through Qualitative Research

In today’s complex healthcare landscape, understanding patient experiences is more crucial than…

Read More
Read More

Empathy, Integrity, and Mindfulness: The Values that Drive Innovation at KJT 

We are immensely proud of our journey from a nascent market research firm in 2007 to a recognized…

Read More
Read More

Generative AI Message Testing – Does it Really Work? 

Message testing is a crucial process for pharmaceutical and biotech companies when evaluating the…

Read More
healthcare provider using generative AI tools
Read More

Using Generative AI for Patient-Centered Market Research – Reality or Myth? 

No matter where you look, generative AI is becoming commonplace. In the realm of healthcare…

Read More
Read More

3 Reasons Why Working in an ESOP Company is Inspiring

When I first came to the United States from Scotland, I wasn’t fully familiar with the idea of…

Read More
Read More

KJT Welcomes Laura McCormick, PhD

KJT is delighted to announce the appointment of Laura McCormick, PhD as the new Vice President of…

Let’s Take Research Further. Together.